Clinical Trials List
2024-10-01 - 2029-09-30
Phase III
Recruiting6
ICD-10C61
Malignant neoplasm of prostate
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9185
Malignant neoplasm of prostate
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/08/01
Investigators and Locations
Co-Principal Investigator
- Shian-Shiang Wang 無
- Jian-Ri Li 無
- Cheng-Che Chen 無
- 蔡世傳 無
- 洪晟鈞 無
- JU-CHUAN HU 無
- Chia-Yen Lin 無
- 梅承恩 無
- 裘坤元 無
- 張瓈文 無
- 王樹吉 Division of Urology
- 廖博崎 Division of Urology
- 林雁婷 無
- Cheng-Kuang Yang 無
- 楊涵中 無
- 張家程 無
- 楊哲瑞 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- JIAN-HUA HONG Division of Urology
- PO-MING CHOW Division of Urology
- 王中傑 Division of Urology
- YU-CHUAN LU Division of Urology
- Ying-Chun Shen 無
- - - 無
- FU-JEN HSUEH 無
- 闕士傑 無
- YEN-HENG LIN 無
- Yeong-Shiau Pu 無
- CHING-CHU LU 無
- Yu-Chieh Tsai 無
- 張尚仁 無
- 吳書丞 無
- JHE-CYUAN GUO 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Wen-Jeng Wu 無
- Ching-Chia Li 無
- 阮雍順 無
- 張顥瀚 無
- 李明儒 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Yi-Hsiu Huang 無
- Tzu-chun Wei 無
- 賴谷順 無
- Jia-An Hong 無
- 蔡承翰 無
- Yen-Hwa Chang 無
- 陳威任 無
- William Huang 無
- I-Shen Huang 無
- Tzu-Ping Lin Division of Urology
- Tzu-Hao Huang 無
- Chien-Hsin Ting 無
- Chih-Chieh Lin 無
- Jiun-I Lai 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Yung-Chang Lin Division of Hematology & Oncology
- 黃文冠 Division of Hematology & Oncology
- 張境夫 Division of Hematology & Oncology
- Yung-Chia Kao Division of Hematology & Oncology
- 余紹銘
- See-Tong Pang Division of Hematology & Oncology
- Chun-Te Wu Division of Hematology & Oncology
- Kai-Jie Yu Division of Hematology & Oncology
- PO-HUNG LIN Division of Hematology & Oncology
- Hong-Cheng Gan Division of Hematology & Oncology
- I-hung Shao Division of Hematology & Oncology
- 黃亮鋼 Division of Hematology & Oncology
- 沈鼎文 Division of Hematology & Oncology
- Feng-Yuan Liu 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Che-Yuan Hu Division of Hematology & Oncology
- Yuh-Shyan Tsai Division of Hematology & Oncology
- Jiann-Hui Ou Division of Hematology & Oncology
- 鍾秉軒 Division of Hematology & Oncology
- Kuan-Yu Wu
- 林琨哲
- Kwang-Yu Chang
- 戴大堯
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
30 participants
-
Global
600 participants